UNITED STATES ANTIMONY CORP - Quarter Report: 2019 March (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark
One)
[X] QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the
quarterly period ended March 31, 2019
[ ]
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition
period __________ to___________
Commission
file number 001-08675
UNITED STATES ANTIMONY CORPORATION
(Exact name of registrant as specified in its
charter)
Montana
|
|
81-0305822
|
(State
or other jurisdiction of incorporation or
organization)
|
|
(I.R.S.
Employer Identification No.)
|
P.O. Box 643, Thompson Falls, Montana
|
|
59873
|
(Address
of principal executive offices)
|
|
(Zip
code)
|
Registrant’s
telephone number, including area code: (406)
827-3523
Indicate
by check mark whether the issuer (1) filed all reports required to
be filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. YES ☒
No
Indicate
by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405
of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files). YES ☒
No
☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definitions of “large accelerated
filer,” “accelerated filer”, “small
reporting company” and “emerging growth company”
in Rule 12b-2 of the Exchange Act.
Large Accelerated
Filer
|
☐
|
Accelerated
Filer
|
☐
|
Non-Accelerated
Filer
|
☐
|
Smaller reporting
company
|
☒
|
|
|
Emerging growth
company
|
☐
|
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company as defined
by Rule 12b-2 of the Exchange Act. YES ☐
No ☒
At May
15, 2019, the registrant had outstanding 68,427,171 shares of par
value $0.01 common stock.
UNITED STATES ANTIMONY CORPORATION
QUARTERLY REPORT ON FORM 10-Q
FOR THE PERIOD
ENDED MARCH 31, 2019
(UNAUDITED)
TABLE OF CONTENTS
|
Page
|
|
|
PART I – FINANCIAL INFORMATION
|
|
|
|
1-14
|
|
|
|
15-18
|
|
|
|
19
|
|
|
|
19
|
|
|
|
PART
II – OTHER INFORMATION
|
|
|
|
20
|
|
|
|
20
|
|
|
|
20
|
|
|
|
20
|
|
|
|
20
|
|
|
|
20
|
|
|
|
21
|
|
|
|
CERTIFICATIONS
|
|
[The
balance of this page has been intentionally left
blank.]
PART
I-FINANCIAL INFORMATION
Item 1. Financial Statements
United States Antimony Corporation and
Subsidiaries
Consolidated Balance Sheets (Unaudited)
ASSETS
|
|
|
|
March 31,
|
December 31,
|
|
2019
|
2018
|
Current
assets:
|
|
|
Cash
and cash equivalents
|
$43,504
|
$56,650
|
Certificates
of deposit
|
253,552
|
252,954
|
Accounts
receivable
|
335,186
|
438,391
|
Inventories
|
887,648
|
755,261
|
Note
receivable - sale of land
|
-
|
400,000
|
Total
current assets
|
1,519,890
|
1,903,256
|
|
|
|
Properties,
plants and equipment, net
|
15,316,467
|
15,227,172
|
Restricted
cash for reclamation bonds
|
57,247
|
57,247
|
IVA
receivable and other assets
|
403,466
|
369,448
|
Total
assets
|
$17,297,070
|
$17,557,123
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
Current
liabilities:
|
|
|
Checks
issued and payable
|
$45,637
|
$46,482
|
Accounts
payable
|
2,045,402
|
1,926,320
|
Due
to factor
|
5,440
|
16,524
|
Accrued
payroll, taxes and interest
|
262,463
|
159,037
|
Other
accrued liabilities
|
378,010
|
353,911
|
Payables
to related party
|
247,731
|
93,567
|
Deferred
revenue
|
32,400
|
32,400
|
Notes
payable to bank
|
113,125
|
183,917
|
Long-term
debt, current portion, net of discount
|
725,317
|
705,460
|
Total
current liabilities
|
3,855,525
|
3,517,618
|
|
|
|
Long-term
debt, net of discount and current portion
|
968,443
|
1,027,730
|
Hillgrove
advances payable
|
1,134,221
|
1,134,221
|
Stock
payable to directors for services
|
206,250
|
175,000
|
Asset
retirement obligations and accrued reclamation costs
|
279,257
|
277,720
|
Total
liabilities
|
6,443,696
|
6,132,289
|
|
|
|
Commitments
and contingencies (Note 4, and 7)
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
Preferred stock $0.01 par value, 10,000,000 shares
authorized:
|
|
|
Series
A: -0- shares issued and outstanding
|
-
|
-
|
Series
B: 750,000 shares issued and outstanding
|
|
|
(liquidation
preference $930,000 and $922,500
|
|
|
respectively)
|
7,500
|
7,500
|
Series
C: 177,904 shares issued and outstanding
|
|
|
(liquidation
preference $97,847 both years)
|
1,779
|
1,779
|
Series
D: 1,751,005 shares issued and outstanding
|
|
|
(liquidation
preference $5,002,470 and $4,961,324
|
|
|
respectively)
|
17,509
|
17,509
|
Common stock, $0.01 par value, 90,000,000 shares
authorized;
|
|
|
68,427,171
and 68,227,171 shares issued and outstanding,
respectively
|
684,271
|
682,271
|
Additional
paid-in capital
|
36,540,874
|
36,406,874
|
Accumulated
deficit
|
(26,398,559)
|
(25,691,099)
|
Total
stockholders' equity
|
10,853,374
|
11,424,834
|
Total
liabilities and stockholders' equity
|
$17,297,070
|
$17,557,123
|
The
accompanying notes are an integral part of the consolidated
financial statements.
1
United States Antimony Corporation and Subsidiaries
Consolidated Statements of Operations - (Unaudited)
|
For the three months ended
|
|
|
March 31,
2019
|
March 31,
2018
|
|
|
|
REVENUES
|
$2,456,365
|
$2,432,929
|
|
|
|
COST OF REVENUES
|
2,525,418
|
2,488,017
|
|
|
|
GROSS PROFIT (LOSS)
|
(69,053)
|
(55,088)
|
|
|
|
OPERATING
EXPENSES:
|
|
|
General
and administrative
|
205,174
|
150,831
|
Salaries
and benefits
|
232,668
|
91,446
|
Other
operating expenses
|
76,130
|
-
|
Professional
fees
|
100,742
|
102,404
|
TOTAL
OPERATING EXPENSES
|
614,714
|
344,681
|
|
|
|
INCOME
(LOSS) FROM OPERATIONS
|
(683,767)
|
(399,769)
|
|
|
|
OTHER
INCOME (EXPENSE):
|
|
|
Interest
income
|
741
|
562
|
Interest
expense
|
(22,488)
|
(23,833)
|
Foreign
exchange gain (loss)
|
-
|
(50,000)
|
Factoring
expense
|
(1,946)
|
(1,400)
|
TOTAL
OTHER INCOME (EXPENSE)
|
(23,693)
|
(74,671)
|
|
|
|
NET LOSS
|
(707,460)
|
(474,440)
|
Preferred
dividends
|
(12,162)
|
(12,162)
|
|
|
|
Net
loss available to common stockholders
|
$(719,622)
|
$(486,602)
|
|
|
|
Net
income (loss) per share of
|
|
|
common
stock:
|
|
|
Basic
and diluted
|
$(0.01)
|
$(0.01)
|
|
|
|
Weighted
average shares outstanding:
|
|
|
Basic
|
68,394,204
|
67,488,063
|
Diluted
|
68,394,204
|
67,488,063
|
2
United States Antimony Corporation and Subsidiaries
Consolidated Statement of Changes in Stockholders' Equity
(Unaudited)
For the periods ended March 31, 2019 and and March 31,
2018
|
|
|
|
|
Additional
|
|
Total
|
|
Total Preferred Stock
|
Common Stock
|
|
Paid
|
Accumulated
|
Stockholders'
|
|
Quarter ended March 31, 2019
|
Shares
|
Amount
|
Shares
|
Amount
|
In Capital
|
Deficit
|
Equity
|
|
|
|
|
|
|
|
|
Balances,
January 1, 2019
|
2,678,909
|
$26,788
|
68,227,171
|
$682,271
|
$36,406,874
|
$(25,691,099)
|
$11,424,834
|
|
|
|
|
|
|
|
|
Issuance
of common stock to chief financial officer
|
|
|
200,000
|
2,000
|
134,000
|
|
136,000
|
|
|
|
|
|
|
|
|
Net
loss
|
|
|
|
|
|
(707,460)
|
(707,460)
|
Balances,
March 31, 2019
|
2,678,909
|
$26,788
|
68,427,171
|
$684,271
|
$36,540,874
|
$(26,398,559)
|
$10,853,374
|
|
|
|
|
|
Additional
|
|
Total
|
|
Total Preferred Stock
|
Common Stock
|
|
Paid
|
Accumulated
|
Stockholders'
|
|
Quarter ended March 31, 2018
|
Shares
|
Amount
|
Shares
|
Amount
|
In Capital
|
Deficit
|
Equity
|
|
|
|
|
|
|
|
|
Balances,
January 1, 2018
|
2,678,909
|
$26,788
|
67,488,153
|
$674,881
|
$36,239,264
|
$(26,564,324)
|
$10,376,609
|
|
|
|
|
|
|
|
|
Net
loss
|
|
|
|
|
|
(474,440)
|
(474,440)
|
Balances,
March 31, 2018
|
2,678,909
|
$26,788
|
67,488,153
|
$674,881
|
$36,239,264
|
$(27,038,764)
|
$9,902,169
|
The
accompanying notes are an integral part of the consolidated
financial statements.
3
United
States Antimony Corporation and Subsidiaries
Consolidated
Statements of Cash Flows (Unaudited)
|
For the three
months ended
|
|
Cash Flows From Operating
Activities:
|
March
31,
2019
|
March
31,
2018
|
Net income
(loss)
|
$(707,460)
|
$(474,440)
|
Adjustments to
reconcile net income (loss) to net cash
|
|
|
provided
(used) by operating activities:
|
|
|
Depreciation and
amortization
|
223,273
|
277,562
|
Amortization of
debt discount
|
18,037
|
21,120
|
Accretion of asset
retirement obligation
|
1,537
|
1,537
|
Common stock issued
for services
|
136,000
|
-
|
Common stock
payable for directors fees
|
31,250
|
43,750
|
Foreign exchange
loss
|
-
|
50,000
|
Other,
net
|
(598)
|
(444)
|
Change
in:
|
|
|
Accounts
receivable
|
103,205
|
(49,967)
|
Inventories
|
(132,387)
|
273,615
|
Other current
assets
|
-
|
4,697
|
IVA receivable and
other assets
|
(34,018)
|
(45,609)
|
Accounts
payable
|
119,082
|
16,202
|
Accrued payroll,
taxes and interest
|
103,426
|
10,015
|
Other accrued
liabilities
|
24,099
|
27,271
|
Deferred
revenue
|
-
|
116
|
Payables to related
party
|
28,964
|
8,236
|
Net cash provided
(used) by operating activities
|
(85,590)
|
163,661
|
|
|
|
Cash Flows From
Investing Activities:
|
|
|
Payment received on
note receivable - sale of land
|
400,000
|
-
|
Purchase
of properties, plants and equipment
|
(312,568)
|
(94,805)
|
Net cash provided
(used) by investing activities
|
87,432
|
(94,805)
|
|
|
|
Cash Flows From
Financing Activities:
|
|
|
Change in checks
issued and payable
|
(845)
|
(17,203)
|
Net borrowing from
factor
|
(11,084)
|
1,870
|
Advance from
related party
|
125,200
|
75,000
|
Principal paid on
notes payable to bank
|
(70,792)
|
(95,448)
|
Principal payments
of net debt
|
(57,467)
|
(48,681)
|
Net cash provided
(used) by financing activities
|
(14,988)
|
(84,462)
|
NET INCREASE
(DECREASE) IN CASH
|
|
|
AND
CASH EQUIVALENTS AND RESTRICTED CASH
|
(13,146)
|
(15,606)
|
Cash and cash
equivalents and restricted cash at beginning of period
|
113,897
|
91,332
|
Cash and cash
equivalents and restricted cash at end of period
|
$100,751
|
$75,726
|
The accompanying notes are an integral part of the consolidated
financial statements.
4
PART I - FINANCIAL INFORMATION, CONTINUED:
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
1.
Basis
of Presentation
The
unaudited consolidated financial statements have been prepared by
the Company in accordance with accounting principles generally
accepted in the United States of America for interim financial
information, as well as the instructions to Form 10-Q. Accordingly,
they do not include all of the information and footnotes required
by accounting principles generally accepted in the United States of
America for complete financial statements. In the opinion of the
Company’s management, all adjustments (consisting of only
normal recurring accruals) considered necessary for a fair
presentation of the interim financial statements have been
included. Operating results for the three month period ended March
31, 2019 are not necessarily indicative of the results that may be
expected for the full year ending December 31, 2019.
For
further information refer to the financial statements and footnotes
thereto in the Company’s Annual Report on Form 10-K for the
year ended December 31, 2018.
Going Concern Consideration
At
March 31, 2019, the Company’s consolidated
financial statements show negative working capital of approximately
$2.3 million and accumulated deficit of approximately $26.4
million. In addition, the Company has a net loss of $707,460
for the first quarter of 2019, and the Company has had recurring
operating losses for most of the prior periods. These factors
indicate that there may be doubt regarding the ability to continue
as a going concern for the next twelve months.
The
continuing losses are principally a result of the Company’s
antimony operations and in particular the production costs incurred
in Mexico.
Regarding the
antimony division, prices were stable or decreased slightly during
the first quarter of 2019 compared to the same quarter in the prior
year, but orders have been strong. For the quarter ended March 31,
2019, the average sale price for antimony is approximately $3.85
per pound compared to a price of $4.04 per pound for the quarter
ended March 31, 2018. In November 2017, the Company renegotiated
its domestic sodium antimonite supply agreement with our North
American supplier resulting in a lower cost per antimony per pound
of approximately $0.44. During 2018, we endured supply
interruptions from our North American supplier, but normal supply
quantities have resumed since 2018. The new supply agreement with
our North American supplier has helped us with cash flow from our
antimony division in 2018 and into 2019.
In
2017, we reduced costs for labor at the Mexico locations which has
resulted in a lower overall production costs in Mexico and we
adjusted operating approaches at Madero that resulted in decreased
operating costs for fuel, natural gas, electricity, and reagents
for 2018 and 2019. The Company’s 2019 plan involves ramping
up production at its antimony properties in Mexico. Our
expectations are that in 2019 we can double the antimony output for
2018. We also are planning to produce and sell antimony metal
directly from Mexico to customers which will save us approximately
$0.38 per pound in processing costs and freight. In addition, a new
leach circuit expected to come on line during 2019 in Mexico will
result in more extraction of precious metals. The portion of the
precious metals recovery system at the Madero smelter is complete
and the cyanide leach circuit being built at the Puerto Blanco
plant is expected to be completed in the second quarter of 2019. We
expect to be receiving income from the production of precious
metals some time during the third quarter of 2019. We believe that
with the lower cost per pound due to increased production and the
savings from shipping metal directly from Mexico, we will have
positive cash flow for Mexican antimony production by the end of
the year and that we will be selling precious metals produced from
Los Juarez before the end of 2019.
5
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
1.
Basis
of Presentation, Continued:
Over the past several years, the Company has been
able to make required principal payments on its debt from cash
generated from operations without the need for additional
borrowings or selling shares of its common stock. The Company plans
to continue keeping current on its debt payments in 2019 through
cash flows from operations while we continue with the expansion of
our Mexican operation. Management believes that the actions taken
to increase production and revenue from both antimony and precious
metals along with a reduction in production costs will enable the
Company to meet its obligations for the next twelve
months.
2.
Developments
in Accounting Pronouncements
Accounting Standards Updates Adopted
In
February 2016, the Financial Accounting Standards Board
(“FASB”) issued Accounting Standards Update
(“ASU”) No. 2016-02 Leases (Topic 842). The
update modified the classification criteria and requires lessees to
recognize the assets and liabilities on the balance sheet for most
leases. The update was effective for fiscal years beginning
after December 15, 2018, with early adoption permitted.
Adoption of this update as of January 1, 2019 did not have a
material impact on the Company’s consolidated financial
statements.
In June
2018, the FASB issued ASU No. 2018-07 Compensation - Stock
Compensation (Topic 718): Improvements to Nonemployee
Share-Based Payment Accounting. The update involves
simplification of several aspects of accounting for nonemployee
share-based payment transactions by expanding the scope of Topic
718 to include nonemployee awards. The update was effective
for fiscal years beginning after December 15, 2018, and interim
periods within those fiscal years, with early adoption
permitted. Adoption of this update as of January 1, 2019 did
not have a material impact on the Company’s consolidated
financial statements.
Accounting Standards Updates to Become Effective in Future
Periods
In
August 2018, the FASB issued ASU No. 2018-13 Fair Value Measurement
(Topic 820): Disclosure Framework - Changes to the Disclosure
Requirements for Fair Value Measurement. The update removes,
modifies and makes additions to the disclosure requirements on fair
value measurements. The update is effective for fiscal years
beginning after December 15, 2019, with early adoption
permitted. Management is evaluating the impact of this update
on the Company’s fair value measurement
disclosures.
6
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
3.
Income
(Loss) Per Common Share
Basic
earnings per share is calculated by dividing net income (loss)
available to common stockholders by the weighted average number of
common shares outstanding during the period. Diluted earnings per
share is calculated based on the weighted average number of common
shares outstanding during the period plus the effect of potentially
dilutive common stock equivalents, including warrants to purchase
the Company's common stock and convertible preferred
stock.
For the
three months ended March 31, 2019 and 2018, the potentially
dilutive common stock equivalents not included in the calculation
of diluted earnings per share as their effect would have been
anti-dilutive are as follows:
|
March 31,
2019
|
March 31,
2018
|
Warrants
|
250,000
|
250,000
|
Convertible
preferred stock
|
1,751,005
|
1,751,005
|
Total
possible dilution
|
2,001,005
|
2,001,005
|
4.
Revenue
Recognition
Our
products consist of the following:
●
Antimony: includes
antimony oxide, sodium antimonate,
antimony trisulfide, and antimony metal
●
Zeolite:
includes coarse and fine zeolite crushed in various
sizes
●
Precious Metals: includes unrefined and
refined gold and silver
For our
antimony and zeolite products, revenue is recognized upon the
completion of the performance obligation which is met when the
transaction price can be reasonably estimated and revenue is
recognized generally at the time when risk is transferred. We have
determined the performance obligation is met and title is
transferred either upon shipment from our warehouse locations or
upon receipt by the customer as specified in individual sales
orders. The performance obligation is met because at that time, 1)
legal title is transferred to the customer, 2) the customer has
accepted the product and obtained the ability to realize all of the
benefits from the product, 3) the customer has the significant
risks and rewards of ownership to it, 4) it is very unlikely
product will be rejected by the customer upon physical receipt, and
5) we have the right to payment for the product. Shipping costs
related to the sales of antimony and zeolite products are recorded
to cost of sales as incurred. For zeolite products, royalty expense
due a third party by the Company is also recorded to cost of sales
upon sale in accordance with terms of underlying royalty
agreements.
For
sales of precious metals, the performance obligation is met, the
transaction price is known, and revenue is recognized at the time
of transfer of control of the agreed-upon metal quantities to the
customer. Refining and shipping costs related to sales of precious
metals are recorded to cost of sales as incurred.
Sales
of products for the three month periods ended March 31, 2019 and
2018, were as follows:
|
Three Months Ended
|
|
|
March 31,
|
|
|
2019
|
2018
|
Antimony
|
$1,705,823
|
$1,681,812
|
Zeolite
|
726,015
|
690,707
|
Precious
metals
|
24,527
|
60,410
|
|
$2,456,365
|
$2,432,929
|
7
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
4.
Revenue
Recognition, continued:
The
following is sales information by geographic area based on the
location of customers for the three month periods ended March 31,
2019 and 2018:
|
Three Months Ended
|
|
|
March 31,
|
|
|
2019
|
2018
|
United
States
|
$2,108,569
|
$2,247,691
|
Canada
|
187,257
|
185,238
|
Mexico
|
160,539
|
-
|
|
$2,456,365
|
$2,432,929
|
Sales
of products to significant customers were as follows for the three
month periods ended March 31, 2019 and 2018:
Sales to Three
|
For the Period Ended
|
|
Largest Customers
|
March 31,
2019
|
March 31,
2018
|
Kohler
Corporation
|
$458,094
|
$316,772
|
Ampacet
Corporation
|
-
|
184,142
|
East
Penn Manufacturing
|
157,328
|
-
|
Mexichem
Speciality Compounds
|
684,011
|
728,578
|
|
$1,299,433
|
$1,229,492
|
% of Total Revenues
|
52.90%
|
50.50%
|
Accounts receivable
from largest customers were as follows at March 31, 2019 and
December 31, 2018:
Three Largest
|
|
|
Accounts Receivable
|
March 31,
2019
|
December 31,
2018
|
DanaMart
|
$-
|
$143,890
|
Axens
North America Inc.
|
64,500
|
34,912
|
Earth
Innovations Inc.
|
-
|
35,967
|
Commerce
Industrial Chemical
|
36,652
|
-
|
Nutreco
Canada Inc.
|
27,736
|
-
|
|
$128,888
|
$214,769
|
% of Total Receivables
|
38.50%
|
49.00%
|
8
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
Our
trade accounts receivable balance related to contracts with
customers was $335,186 at March 31, 2019 and $438,391 at
December 31, 2018. Our products do not involve any warranty
agreements and product returns are not typical.
We have
determined our contracts do not include a significant financing
component. For antimony and zeolite sales contracts, we may factor
certain receivables and receive final payment within 30 days of the
performance obligation being met. For antimony and zeolite
receivables not factored, we typically receive payment within 10
days. For precious metals sales, a provisional payment of 75% is
typically received within 45 days of the date the product is
delivered to the customer. After an exchange of assays, a final
payment is normally received within 90 days of product
delivery.
5.
Inventories
Inventories at
March 31, 2019 and December 31, 2018 consisted primarily of
finished antimony products, antimony metal, antimony ore, and
finished zeolite products that are stated at weighted average lower
of cost or estimated net realizable value. Finished antimony
products, antimony metal and finished zeolite products costs
include raw materials, direct labor and processing facility
overhead costs and freight. Inventory at March 31, 2019 and
December 31, 2018, is as follows:
|
March 31,
|
December 31,
|
|
2019
|
2018
|
Antimony
Metal
|
$158,532
|
$8,127
|
Antimony
Oxide
|
252,704
|
255,782
|
Antimony
Concentrates
|
-
|
2,214
|
Antimony
Ore
|
269,627
|
257,067
|
Total
antimony
|
680,863
|
523,190
|
Zeolite
|
206,785
|
232,071
|
|
$887,648
|
$755,261
|
6.
Accounts
Receivable and Due to Factor
The
Company factors designated trade receivables pursuant to a
factoring agreement with LSQ Funding Group L.C., an unrelated
factor (the “Factor”). The agreement
specifies that eligible trade receivables are factored with
recourse. We submit selected trade receivables to the factor, and
receive 83% of the face value of the receivable by wire transfer.
The Factor withholds 15% as retainage, and 2% as a servicing fee.
Upon payment by the customer, we receive the remainder of the
amount due from the factor. The 2% servicing fee is recorded on the
consolidated statement of operations in the period of sale to the
factor. John Lawrence, CEO, is a personal guarantor of the
amount due to Factor.
Trade
receivables assigned to the Factor are carried at the original
invoice amount less an estimate made for doubtful
accounts. Under the terms of the recourse provision, the
Company is required to reimburse the Factor, upon demand, for
factored receivables that are not paid on
time. Accordingly, these receivables are accounted for
as a secured financing arrangement and not as a sale of financial
assets. The allowance for doubtful accounts (if any) is based
on management’s regular evaluation of individual
customer’s receivables and consideration of a
customer’s financial condition and credit
history. Trade receivables are written off when deemed
uncollectible. Recoveries of trade receivables
previously written off are recorded when
received. Interest is not charged on past due
accounts.
We
present the receivables, net of allowances, as current assets and
we present the amount potentially due to the Factor as a secured
financing in current liabilities.
Accounts Receivble
|
March 31,
2019
|
December 31,
2018
|
Accounts
receivable - non factored
|
$329,746
|
$421,867
|
Accounts
receivable - factored with recourse
|
5,440
|
16,524
|
Accounts
receivable - net
|
$335,186
|
$438,391
|
9
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
7.
Commitments
and Contingencies
In June
of 2013, the Company entered into a lease to mine antimony ore from
concessions located in the Wadley Mining district in Mexico. The
lease calls for a term of one year, and as of March 31, 2019,
requires payments of $10,000 plus a tax of $1,700, per month. The
lease is renewable each year with a 15 day notice to the lessor,
and agreement of terms. The next lease renewal is scheduled for
renewal in June 2019.
8.
Notes
Payable to Bank
At
March 31, 2019 and December 31, 2018, the Company had the following
notes payable to bank:
|
March 31,
|
December 31,
|
|
2019
|
2018
|
Promissory
note payable to First Security Bank of Missoula,
|
|
|
bearing
interest at 3.150%, payable on demand, collateralized
|
|
|
by
a lien on Certificate of Deposit
|
$13,126
|
$83,918
|
|
|
|
Promissory
note payable to First Security Bank of Missoula,
|
|
|
bearing
interest at 3.150%, payable on demand, collateralized
|
|
|
by
a lien on Certificate of Deposit
|
99,999
|
99,999
|
|
|
|
Total
notes payable to the bank
|
$113,125
|
$183,917
|
These
notes are personally guaranteed by John C. Lawrence the
Company’s Chief Executive Officer and Chairman of the Board
of Directors. The maximum amount available for borrowing under each
note is $99,999.
10
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited),
Continued:
9.
Debt
Long-Term
debt at March 31, 2019 and December 31, 2018 is as
follows:
|
March 31,
|
December 31,
|
|
2019
|
2018
|
Note payable to Zeo Inc., non interest bearing, payable
in 11 quarterly installments of $8,300 with a final payment of
$8,700; maturing
December 2022; uncollateralized.
|
$100,000
|
$100,000
|
|
|
|
Note payable to Cat Financial Services, bearing interest at
6%; payable
in monthly installments of $1,300; maturing August
2019; collateralized by equipment.
|
9,088
|
14,022
|
|
|
|
Note payable to Cat Financial Services, bearing interest at
6%; payable
in monthly installments of $778; maturing December
2022; collateralized by equipment.
|
31,940
|
34,390
|
|
|
|
Note payable to De Lage Landen Financial Services,
bearing
interest at 3.51%; payable in monthly installments of $655;
maturing
September 2019; collateralized by equipment.
|
3,294
|
5,851
|
|
|
|
Note payable to De Lage Landen Financial Services,
bearing
interest at 3.51%; payable in monthly installments of $655;
maturing
December 2019; collateralized by equipment.
|
5,844
|
8,371
|
|
|
|
Note payable to Phyllis Rice, bearing interest at
1%; payable in monthly installments of $2,000; originally
maturing March
2015; collateralized by equipment.
|
9,146
|
12,146
|
|
|
|
Obligation payable for Soyatal Mine, non-interest bearing,
annual
payments of $100,000 or $200,000 through 2020, net of
discount of
$19,156 and $23,321, respectively. In addition, the Company is
deliquent on payments
of $392,069 related to this loan.
|
623,913
|
639,747
|
|
|
|
Obligation payable for Guadalupe Mine, non-interest bearing,
annual
payments from $60,000 to $149,078 through 2026, net of
discount of
$238,572 and $252,444, respectively. In addition, the Company is
delinquent on
payments of $32,539 related to this loan.
|
910,535
|
918,663
|
|
1,693,760
|
1,733,190
|
Less
current portion
|
(725,317)
|
(705,460)
|
Long-term
portion
|
$968,443
|
$1,027,730
|
At
March 31, 2019, principal payments on debt are due as
follows:
3 Months Ending March 31,
|
Principal Payment
|
Discount
|
Net
|
2020
|
$791,908
|
$(66,591)
|
$725,317
|
2021
|
264,928
|
(51,140)
|
213,788
|
2022
|
190,396
|
(40,765)
|
149,631
|
2023
|
182,996
|
(34,266)
|
148,730
|
2024
|
149,078
|
(27,378)
|
121,700
|
Thereafter
|
371,181
|
(36,587)
|
334,594
|
|
$1,950,487
|
$(256,727)
|
$1,693,760
|
11
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited),
Continued:
10.
Related
Party Transactions
During
the three months ended March 31, 2019 and 2018, the Chairman of the
audit committee and compensation committee received $0 and $4,500,
respectively, for services performed. See Note 11 for shares of
common stock issued to directors.
During
the three months ended March 31, 2019 and 2018, the Company paid
$1,584 and $2,461, respectively, to John Lawrence, our President
and Chief Executive Officer, as reimbursement for equipment used by
the Company. Mr. Lawrence advanced the Company $125,200 for ongoing
operating expenses during the quarter ended March 31,
2019.
11.
Stockholder’s Equity
Issuance of Common Stock for Payable to Board of
Directors
During
the quarters ended March 31, 2019 and March 31, 2018, the Company
accrued $31,250 and $43,750, respectively, in directors’ fees
payable that will be paid in common stock.
In
January 2019, the Company issued Daniel Parks, the Company’s
Chief Financial Officer, 200,000 shares of the Company’s
common stock with a fair value of $136,000 to retain his services.
As part of the agreement, Mr. Parks’ hours worked and
financial compensation have been reduced.
12.
Plant
Acquisition
On
August 31, 2018, the Company closed a Member Interest and Capital
Share Agreement (the
“Agreement”) with Great Lakes Chemical Corporation and
Lanxess Holding Company US Inc., as the sellers, and the Company as
the buyer. Under the Agreement, the Company acquired a subsidiary
of the sellers which includes an antimony plant, equipment and land
located in Reynosa, Mexico. The Company is
disassembling, salvaging and transporting the antimony plant and
equipment for use in its existing operations in both Mexico and the
United States. The project involves moving heavy equipment and
could take up to a year. In addition, the Company was paid
$1,500,000 by the sellers, which was recognized as operating income
in the quarter ended September 30, 2018, to assist in the salvage
and transport costs of the useable equipment. The transaction was
accounted for as an asset acquisition as there was no business
associated with the acquired assets. As of March 31, 2019, we have
substantially completed the demolition and transportation of the
salvaged equipment. The real property acquired with the plant was
sold for $700,000 in November 2018, for which the Company received
$300,000 in 2018 and the remaining balance of $400,000 in the three
month period ended March 31, 2019.
13.
Business
Segments
The
Company is currently organized and managed by four segments, which
represent our operating units: United States antimony operations,
Mexican antimony operations, precious metals recovery and United
States zeolite operations.
The
Madero smelter and Puerto Blanco mill at the Company’s Mexico
operation brings antimony up to an intermediate stage, which may be
sold directly or shipped to the United States operation for
finishing at the Thompson Falls, Montana plant. The precious metals
recovery plant is operated in conjunction with the antimony
processing plant at Thompson Falls, Montana. The zeolite operation
produces zeolite near Preston, Idaho. Almost all of the sales of
products from the United States antimony and zeolite operations are
to customers in the United States.
12
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited),
Continued:
14.
Business
Segments, continued:
Segment
disclosure regarding sales to major customers is located in Note
4.
Properties,
plants
and equipment, net:
|
March 31,
2019
|
December 31,
2018
|
Antimony
|
|
|
United
States
|
$1,625,783
|
$1,635,315
|
Mexico
|
11,786,592
|
11,660,769
|
Subtotal
Antimony
|
13,412,375
|
13,296,084
|
Precious
metals
|
605,462
|
615,719
|
Zeolite
|
1,298,630
|
1,315,369
|
Total
|
$15,316,467
|
$15,227,172
|
Total Assets:
|
March 31,
2019
|
December 31,
2018
|
Antimony
|
|
|
United
States
|
$2,183,085
|
$2,199,694
|
Mexico
|
12,616,734
|
12,824,292
|
Subtotal
Antimony
|
14,799,819
|
15,023,986
|
Precious
metals
|
605,462
|
615,719
|
Zeolite
|
1,891,789
|
1,917,418
|
Total
|
$17,297,070
|
$17,557,123
|
|
For the three months ended
|
|
Capital expenditures:
|
March 31,
2019
|
March 31,
2018
|
Antimony
|
|
|
United
States
|
$1,345
|
$-
|
Mexico
|
274,906
|
40,085
|
Subtotal
Antimony
|
276,251
|
40,085
|
Precious
Metals
|
6,754
|
40,988
|
Zeolite
|
29,563
|
13,732
|
Total
|
$312,568
|
$94,805
|
13
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited),
Continued:
14.
Business
Segments, continued:
Segment Operations for the three
|
Antimony
|
Antimony
|
Total
|
Precious
|
Bear River
|
|
months ended March 31, 2019
|
USAC
|
Mexico
|
Antimony
|
Metals
|
Zeolite
|
Totals
|
|
|
|
|
|
|
|
Total
revenues
|
$1,545,284
|
$160,539
|
$1,705,823
|
$24,527
|
$726,015
|
$2,456,365
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
10,878
|
149,083
|
159,961
|
17,011
|
46,301
|
223,273
|
|
|
|
|
|
|
|
Income
(loss) from operations
|
(52,096)
|
(802,676)
|
(854,772)
|
7,516
|
163,489
|
(683,767)
|
|
|
|
|
|
|
|
Other
income (expense):
|
(1,367)
|
(18,287)
|
(19,654)
|
-
|
(4,039)
|
(23,693)
|
|
|
|
|
|
|
|
NET INCOME (LOSS)
|
$(53,463)
|
$(820,963)
|
$(874,426)
|
$7,516
|
$159,450
|
$(707,460)
|
Segment Operations for the three
|
Antimony
|
Antimony
|
Total
|
Precious
|
Bear River
|
|
months ended March 31, 2018
|
USAC
|
Mexico
|
Antimony
|
Metals
|
Zeolite
|
Totals
|
|
|
|
|
|
|
|
Total
revenues
|
$1,681,812
|
$-
|
$1,681,812
|
$60,410
|
$690,707
|
$2,432,929
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
13,209
|
149,004
|
162,213
|
67,529
|
47,820
|
277,562
|
|
|
|
|
|
|
|
Income
(loss) from operations
|
198,039
|
(742,781)
|
(544,742)
|
(7,119)
|
152,092
|
(399,769)
|
|
|
|
|
|
|
|
Other
income (expense):
|
(778)
|
(71,120)
|
(71,898)
|
-
|
(2,773)
|
(74,671)
|
|
|
|
|
|
|
|
NET INCOME (LOSS)
|
$197,261
|
$(813,901)
|
$(616,640)
|
$(7,119)
|
$149,319
|
$(474,440)
|
14
ITEM 2. Management’s Discussion and Analysis of
Results of Operations and Financial Condition
General
Certain
matters discussed are forward-looking statements that involve risks
and uncertainties, including the impact of antimony prices and
production volatility, changing market conditions and the
regulatory environment and other risks. Actual results may differ
materially from those projected. These forward-looking statements
represent our judgment as of the date of this filing. We disclaim,
however, any intent or obligation to update these forward-looking
statements.
Antimony - Combined USA
|
1st Quarter
|
1st Quarter
|
and Mexico
|
2019
|
2018
|
Lbs
of Antimony Metal USA
|
233,596
|
263,620
|
Lbs
of Antimony Metal Mexico:
|
209,552
|
152,344
|
Total Lbs of Antimony Metal Sold
|
443,148
|
415,964
|
Average
Sales Price/Lb Metal
|
$3.85
|
$4.04
|
Net loss/Lb Metal
|
$(1.97)
|
$(1.48)
|
|
|
|
Gross
antimony revenue - net of discount
|
$1,705,823
|
$1,681,812
|
|
|
|
Cost
of sales
|
(1,963,964)
|
(1,906,002)
|
Operating
expenses
|
(596,631)
|
(320,552)
|
Non-operating
expenses
|
(19,654)
|
(71,898)
|
|
(2,580,249)
|
(2,298,452)
|
|
|
|
Net loss - antimony
|
(874,426)
|
(616,640)
|
Depreciation,&
amortization
|
159,961
|
162,213
|
EBITDA - antimony
|
$(714,465)
|
$(454,427)
|
|
|
|
Precious Metals
|
|
|
Ounces sold
|
|
|
Gold
|
6
|
12
|
Silver
|
1,724
|
4,073
|
|
|
|
Gross
precious metals revenue
|
$24,527
|
$60,410
|
Production
costs, royalties, and shipping costs
|
(17,011)
|
(67,529)
|
Net income (loss) - precious metals
|
7,516
|
(7,119)
|
Depreciation
|
17,011
|
67,529
|
EBITDA - precious metals
|
$24,527
|
$60,410
|
|
|
|
Zeolite
|
|
|
Tons sold
|
3,841
|
3,753
|
Average
Sales Price/Ton
|
$189.02
|
$184.04
|
Net income/Ton
|
$41.51
|
$39.79
|
|
|
|
Gross
zeolite revenue
|
$726,015
|
$690,707
|
Cost
of sales
|
(544,443)
|
(514,486)
|
Operating
expenses
|
(18,083)
|
(24,129)
|
Non-operating
expenses
|
(4,039)
|
(2,773)
|
Net income - zeolite
|
159,450
|
149,319
|
Depreciation
|
46,301
|
47,820
|
EBITDA - zeolite
|
$205,751
|
$197,139
|
|
|
|
Company-wide
|
|
|
Gross
revenue
|
$2,456,365
|
$2,432,929
|
Production
costs
|
(2,525,418)
|
(2,488,017)
|
Operating
expenses
|
(614,714)
|
(344,681)
|
Non-operating
expenses
|
(23,693)
|
(74,671)
|
Net income (loss)
|
(707,460)
|
(474,440)
|
Depreciation,&
amortization
|
223,273
|
277,562
|
EBITDA
|
$(484,187)
|
$(196,878)
|
|
|
|
15
PART I - FINANCIAL INFORMATION, CONTINUED:
ITEM
2. Management’s Discussion and Analysis of Results of
Operations and Financial Condition, continued:
Company-Wide
For the
first quarter of 2019, we recognized a net loss of $707,460, on
sales of $2,456,365, compared to a net loss of $474,440 in the
first quarter of 2018 on sales of $2,432,929. In addition to
normal operating costs, the loss in the first quarter of 2019 was
primarily due to the one time cost to demolish the Lanxess plant in
Reynosa, Mexico ($76,130), an increase in administrative salaries
paid by issuance of stock ($136,000), a reduction in precious
metals revenue ($35,883), and the cost of the listing on the NYSE
($60,000). The loss in the first quarter of 2018 was
primarily due to decrease in the raw materials received from our
North American supplier. During 2018, we endured supply
interruptions from our North American supplier, but we anticipate
that near normal supply quantities will resume for the remainder of
2019.
For the
first quarter of 2019, EBITDA was a negative $484,187 compared to a
negative $196,878 for the same period of 2018.
Net
non-cash expense items totaled $410,347 for 2019 and included
$223,273 for depreciation and amortization, $18,037 for
amortization of debt discount, $31,250 for director compensation,
$136,000 for stock issued for employment, and $1,787 for other
items.
Net
non-cash expense items totaled $343,969 for the first quarter of
2018 and included $277,562 for depreciation and amortization,
$21,120 for amortization of debt discount, $43,750 for director
compensation and $1,537 for other items.
For the
first quarter of 2019, general and administrative expenses were
$205,174 compared to $150,831 for the same period of
2018.
Antimony
For the
three months ended March 31, 2019, we sold 443,148 pounds of
antimony compared to 415,964 pounds for the three months ended
March 31, 2018. The raw material received from our North American
supplier decreased by approximately 30,000 pounds for the three
months ended March 31, 2019, compared to the same quarter for 2018.
We had a increase in raw material of approximately 57,000 pounds
from Mexico for the first quarter of 2019 compared to the same
quarter for 2018.
The
average sales price of antimony during the three months ended March
31, 2019 was $3.85 per pound compared to $4.04 during the same
period in 2018.
The
cyanide leach circuit at Puerto Blanco has been permitted, and
construction of the leach circuit is underway and is nearly
complete. The largest project was the construction of the tailings
pond, and it is ready for a liner.
At the
Wadley mine, production is being increased with more miners and
load haul dump equipment. The use of pneumatic hammers is planned
in lieu of explosives. We believe that we can double our production
from this mine in 2019.
The
Guadalupe mine has started production, and will be shipping direct
shipping ore to our Madero smelter during 2019.
The
Soyatal mine will be started once we receive an explosives
permit.
16
Precious Metals
The
caustic leach of flotation concentrates from Los Juarez was
successful, and the pilot production of the Los Juarez gold,
silver, and antimony will commence with the completion of the
cyanide leach plant at Puerto Blanco. The cyanide leach plant at
Puerto Blanco is on schedule to start testing in quarter two of
2019. Tests will include three technical discoveries that we expect
to increase recovery and expedite processing.
For the
three months ended March 31, 2019, income for precious metals was
$24,527, compared to $60,410 for the same period of
2018.
The
estimated recovery of precious metals per metric ton, after the
caustic leach and cyanide leach circuits, is as
follows:
Metal
|
|
Assay
|
|
Recovery
|
|
Value
|
|
Value/Mt
|
Gold
|
|
0.035 opmt
|
|
90%
|
|
$1200/oz
|
|
$37.80
|
Silver
|
|
3.27 opmt
|
|
90%
|
|
$15.50/oz
|
|
$45.61
|
Antimony
|
|
0.652%
|
|
70%
|
|
4.14/lb
|
|
$41.52
|
Total
|
|
|
|
|
|
|
|
$124.93
|
Current
and prior years’ revenue from precious metals is as
follows:
Precious Metal Sales
Silver/Gold
|
||
Montana
|
2019
|
2018
|
Ounces
Gold Shipped (Au)
|
6.45
|
11.59
|
Ounces
Silver Shipped (Ag)
|
1,724.40
|
4,073.27
|
Total Revenues
|
$24,527
|
$60,410
|
Bear River Zeolite (BRZ)
For the
three months ended March 31, 2019, BRZ sold 3,841 tons of zeolite
compared to 3,753 tons in the same period of 2018, up 88 tons
(2%).
BRZ
realized net income of $159,450 after depreciation of $46,301 in
the first quarter of 2019, compared to a net income of $149,319
after depreciation of $47,820 for the same quarter of
2018.
BRZ
realized an EBITDA for the three months ended March 31, 2019 of
$205,571, compared to $197,319 for the same period in
2018.
We are
anticipating continued growth in all areas of zeolite
sales.
17
Financial Position
Financial Condition and Liquidity
|
|
|
|
March 31,
2019
|
December 31,
2018
|
Current
assets
|
$1,519,890
|
$1,903,256
|
Current
liabilities
|
(3,855,525)
|
(3,517,618)
|
Net
Working Capital
|
$(2,335,635)
|
$(1,614,362)
|
|
For the Three Months Ended
|
|
|
March 31,
2019
|
March 31,
2018
|
Cash
provided (used) by operations
|
$(85,590)
|
$163,661
|
Cash
provided by collection of note receivable
|
400,000
|
-
|
Cash
used for capital outlay
|
(312,568)
|
(94,805)
|
Cash
provided (used) by financing:
|
|
|
Net
payments (to) from factor
|
(11,084)
|
1,870
|
Payments
on notes payable to bank
|
(70,792)
|
(95,448)
|
Principal
paid on long-term debt
|
(57,467)
|
(48,681)
|
Advance
from related party
|
125,200
|
75,000
|
Checks
issued and payable
|
(845)
|
(17,203)
|
Net
change in cash and cash equivalents
|
$(13,146)
|
$(15,606)
|
Our net
working capital decreased by approximately $721,273 from December
31, 2018. Our cash and cash equivalents decreased by approximately
$13,000 during the same period. The decrease in our net working
capital was partially due to $76,000 for decommissioning an
antimony plant in Reynosa, Mexico, and an increase of approximately
$160,000 in the liabilities in Mexico. We spent approximately
$312,000 for capital items, including the capitalized portion of
demolishing the Lanxess plant in Reynosa, Mexico, and our long term
debt decreased by approximately $59,000. We have estimated
commitments for construction and improvements of $100,000 to finish
building and installing the precious metals leach circuits. We
believe that with our current cash balance, along with the future
cash flow from operations and operating agreements, we have
adequate liquid assets to meet these commitments and service our
debt for the next twelve months. We have lines of credit of
$202,000 which have been drawn down by $113,125 at March 31,
2019.
18
ITEM
3.
None
ITEM 4. Controls and
Procedures
EVALUATION
OF DISCLOSURE CONTROLS AND PROCEDURES
We
maintain disclosure controls and procedures that are designed to
ensure that information required to be disclosed in our reports
under the Securities Exchange Act of 1934 is recorded, processed,
summarized and reported within the time periods specified in the
SEC's rules and forms, and that such information is accumulated and
communicated to management, as appropriate, to allow timely
decisions regarding required disclosure. Our chief financial
officer conducted an evaluation of the effectiveness of the
Company's disclosure controls and procedures (as defined in the
Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as
of March 31, 2019. It was determined that there were material
weaknesses affecting our disclosure controls and procedures and, as
a result of those weaknesses, our disclosure controls and
procedures were not effective as of March 31, 2019. These material
weaknesses are as follows:
●
Inadequate design
of internal control over the preparation of the financial
statements and financial reporting processes;
●
Inadequate
monitoring of internal controls over significant accounts and
processes including controls associated with domestic and Mexican
subsidiary operations and the period-end financial reporting
process; and
●
The absence of
proper segregation of duties within significant processes and
ineffective controls over management oversight, including antifraud
programs and controls.
We are
aware of these material weaknesses and will develop procedures to
ensure that independent review of material transactions is
performed. The chief financial officer will develop internal
control measures to mitigate the lack of inadequate documentation
of controls and the monitoring of internal controls over
significant accounts and processes including controls associated
with the period-ending reporting processes, and to mitigate the
segregation of duties within significant accounts and processes and
the absence of controls over management oversight, including
antifraud programs and controls.
We plan
to consult with independent experts when complex transactions are
entered into.
CHANGES
IN INTERNAL CONTROL OVER FINANCIAL REPORTING
There were no significant changes made to
internal controls over financial reporting for the quarter ended
March 31, 2019.
19
PART
II - OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
None
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE
OF PROCEEDS
None
Item 3. DEFAULTS UPON SENIOR SECURITIES
The
registrant has no outstanding senior securities.
Item 4. MINE SAFETY DISCLOSURES
The
information concerning mine safety violations or other regulatory
matters required by Section 1503 (a) of the Dodd-Frank Wall Street
Reform and Consumer Protection Act and Item 104 of Regulation S-K
is included in Exhibit 95 to this Annual Report.
Item 5. OTHER INFORMATION
None
Item 6. EXHIBITS AND REPORTS ON FORM 8-K
Certifications
Certifications
Pursuant to the Sarbanes-Oxley Act
Reports on Form
8-K None
20
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(b) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly
authorized.
|
UNITED STATES
ANTIMONY CORPORATION
(Registrant)
|
|
|
|
|
|
|
Date: May 15,
2019
|
By:
|
/s/ John C.
Lawrence
|
|
|
|
John C. Lawrence, Director and President |
|
|
|
(Principal Executive) |
|
|
|
|
|
|
|
|
|
Date: May 15, 2019 |
By:
|
/s/ Daniel L.
Parks
|
|
|
|
Daniel L. Parks, Chief Financial Officer |
|
|
|
|
|
21